The consent order mandates divestitures across five metro areas after regulators concluded the acquisition would reduce competition for key outpatient surgical services.
Companies that secretly vary prices based on how much they think individual customers will pay could be violating the FTC Act.
The agency has signaled broader interest in ensuring that companies operating in the health‑tech ecosystem maintain transparent data policies and do not engage in conduct that could disadvantage patients or healthcare providers.
The agency is the latest to drop the doctrine pursuant to a 2025 Trump executive order.
The DOJ’s Antitrust Division is returning to targeted Second Request investigations.
Federal regulators and two states claim company charged prematurely, hindered cancellations, and shared sensitive information with advertisers.
Key personnel moves across the regulated industries that we cover.
The Federal Trade Commission says the settlement will increase transparency and competition across the entire drug supply chain.
